Cancer Research UK Manchester Centre
- Research works
- 31 ▲ 363% vs 2013–17
- Citations
- 898 28.7 per fractional work
- Top-10% rate
- 19.2% record average 16.5%
- Open access
- 71% world 28%
Not ranked overall: Cancer Research UK Manchester Centre is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.1×. Every wedge is a field page.
Which keywords describe research at Cancer Research UK Manchester Centre?
By fractional works in all years, weighted toward what it does more of than the world: Immunotherapy, Clinical Trials, Biomarkers, Lymphoma, Chemotherapy, Genomic Profiling, Targeted Therapy and Rituximab.
- Cell Death
- Tumor Regression
- Epidemiology
- CAR T Cells
- Leukemia
- Precision Medicine
- PET Imaging
- Genetic Pathogenesis
- Androgen Receptor
- Hormone Therapy
- Cancer Immunotherapy
- Cancer Therapy
- Genetic Mutations
- Prostate Cancer
- Targeted Therapy
- Cancer
- Lymphoma
- Clinical Trials
- Immunotherapy
- Biomarkers
- Chemotherapy
- Genomic Profiling
- Rituximab
- Radiotherapy
- Tumor Microenvironment
- Genomic Instability
- Gene Expression Profiling
- Molecular Profiling
- Classification
- Metastatic Prostate Cancer
- Prognostic Factors
- Homologous Recombination
- Adjuvant Therapy
- Chimeric Antigen Receptor
- Human Papillomavirus
- Breast Cancer
- Chromatin
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 37 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 37 words, with their numbers
- Immunotherapy4▲ 18×11 topics
- Clinical Trials3▲ 16×6 topics
- Biomarkers3▲ 14×9 topics
- Lymphoma3▲ 57×3 topics
- Chemotherapy3▲ 12×15 topics
- Cancer2▲ 5.5×21 topics
- Genomic Profiling2▲ 78×2 topics
- Targeted Therapy2▲ 34×4 topics
- Rituximab2▲ 44×2 topics
- Prostate Cancer2▲ 43×3 topics
- Radiotherapy2▲ 16×9 topics
- Genetic Mutations2▲ 11×7 topics
- Tumor Microenvironment2▲ 17×4 topics
- Cancer Therapy2▲ 8.4×9 topics
- Genomic Instability2▲ 42×3 topics
- Cancer Immunotherapy2▲ 36×3 topics
- Gene Expression Profiling2▲ 51×2 topics
- Hormone Therapy2▲ 48×2 topics
- Molecular Profiling2▲ 42×2 topics
- Androgen Receptor2▲ 52×1 topic
- Classification2▲ 13×1 topic
- Genetic Pathogenesis2▲ 81×1 topic
- Metastatic Prostate Cancer2▲ 109×1 topic
- PET Imaging2▲ 22×2 topics
- Prognostic Factors2▲ 10×9 topics
- Precision Medicine1▲ 14×5 topics
- Homologous Recombination1▲ 57×2 topics
- Leukemia1▲ 57×2 topics
- Adjuvant Therapy1▲ 30×2 topics
- CAR T Cells1▲ 79×1 topic
- Chimeric Antigen Receptor1▲ 79×1 topic
- Epidemiology1▼ 0.84×11 topics
- Human Papillomavirus1▲ 29×3 topics
- Tumor Regression1▲ 42×2 topics
- Breast Cancer1▲ 12×8 topics
- Cell Death1▲ 16×5 topics
- Chromatin1▲ 36×2 topics
Which research topics does Cancer Research UK Manchester Centre publish most on?
By volume in 2022–2025: Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, Genital Health and Disease and CAR-T cell therapy research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 1 works
- 2 Chronic Lymphocytic Leukemia Research Genetics 1 works
- 3 Genital Health and Disease Surgery 0 works
- 4 CAR-T cell therapy research Oncology 0 works
- 5 Cancer Genomics and Diagnostics Cancer Research 0 works
- 6 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works
- 7 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 0 works
- 8 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
- 9 Cancer survivorship and care Oncology 0 works
- 10 Cancer Immunotherapy and Biomarkers Oncology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Cancer Research UK Manchester Centre's research output changed?
Output in 2018–2022 was 363% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.